G. Guzelant And Z. Ongen, "Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2, 2017
Guzelant, G. And Ongen, Z. 2017. Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2 .
Guzelant, G., & Ongen, Z., (2017). Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2.
Guzelant, G., And Z. Ongen. "Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2, 2017
Guzelant, G. And Ongen, Z.. "Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2, 2017
Guzelant, G. And Ongen, Z. (2017) . "Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2.
@article{article, author={G. Guzelant And author={Z. Ongen}, title={Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2017}